iX Biopharma Ltd., a Singapore public─listed specialty pharmaceutical and nutraceutical company, has received the approval by Therapeutic Goods Administration (TGA), the regulatory authority in Australia
More From BioPortfolio on "iX Biopharma's male erectile dysfunction drug, Silcap receives Australian approvals"